Stocks · Health care · Pharmaceutical Preparations

ANAPTYSBIO, INC

ANAB Clue Score43
United States Fiscal year ends June CIK 0001370053 Results filed 12 May 2026

What the insiders did No buying or selling

By person

12 insiders · 0 transactions
35.0×

Daniel Faga holds 35.0 times base salary in stock. $24.74M of shares against $706.01K in salary for 2025.

Salary from the company's own proxy. The shares are what Daniel Faga last reported holding, valued at $49.87, the price Common Stock was last bought or sold at on the open market here, on 1 Oct 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
EcoR1 Capital, LLC entity
Director
—
—
—
7,880,094
$393.01M
+1.1%
Daniel Faga
President, CEO
—
—
—
495,965
$24.74M
+22.3%
Paul F. Lizzul
Chief Medical Officer
—
—
—
42,088
$2.10M
+149.6%
John P. Schmid
Director
—
—
—
37,652
$1.88M
+865.4%
Dennis Mulroy
Chief Financial Officer
—
—
—
21,852
$1.09M
+210.0%
John A Orwin
Director
—
—
—
17,995
$897.49K
+439.6%
Eric J Loumeau
Chief Legal Officer
—
—
—
12,835
$640.14K
+172.7%
Rita Jain
Director
—
—
—
11,864
$591.71K
+161.7%
Hollings Renton
Director
—
—
—
10,995
$548.37K
+463.8%
Magda Marquet
Director
—
—
—
9,930
$495.25K
+154.6%
J. Anthony Ware
Director
—
—
—
9,630
$480.29K
+28.4%
Dennis M Fenton
Director
—
—
—
4,965
$247.63K
+154.6%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.